ONAGRE 1050 mg 60 Capsules Molles
Food supplement declared in France, declaration No 2019-4-967
ONAGRE 1050 mg 60 Capsules Molles (PROZIS) is a food supplement declared in France. Status: withdrawn from the market on 27 September 2026. Main ingredients: Oenothera biennis 3,150 mg per day, Vitamin E. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked. Its name nevertheless states a dose above the maximum set in France in 2006: see the composition.
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Withdrawn from the market on 27 September 2026
- Form
- Capsule
- Daily dose
- 3 capsules molles
- Directions for use
- Prendre 1 capsule molle 3 fois par jour.
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant
Declaration 163744, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Oenothera biennis L. | Graine (huile) | Pression à froid | 3,150 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-alpha-tocopherol | Vitamin E | 300 mg | 30 mg |
The product name states 1,050 mg of vitamine E per serving, above the maximum dose of 30 mg set by the Order of 9 May 2006, not revised since November 2006. Check the dose and number of servings on the label. The EFSA The tolerable upper intake level for adults, including food, is 300 mg per day.
Additives
E422, E306, E304, E310
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Veuillez consulter un médecin avant d'utiliser ce produit si vous êtes enceintes ou si vous allaitez. Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
- Information
Withdrawn from the market on 27 September 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Oenothera biennis L.
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ONAGRE 1050 mg 60 Capsules Molles (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/163744-onagre-1050-mg-60-capsules-molles, updated 15 November 2026.